1. The Long-Term DEHP Exposure Confers Multidrug Resistance of Triple-Negative Breast Cancer Cells through ABC Transporters and Intracellular ROS
   Mahendra Jadhao et al, 2021, Antioxidants CrossRef
2. HOX family transcription factors: Related signaling pathways and post-translational modifications in cancer
   Miao Yu et al, 2020, Cellular Signalling CrossRef
3. Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations
   Chenyue Zhang et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
4. A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy
   Shiwei Niu et al, 2019, Chemical Engineering Journal CrossRef
5. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
   Yueping Zhan et al, 2020, Cancer Science CrossRef
6. Dexmedetomidine impairs P‑glycoprotein‑mediated efflux function in L02 cells via the adenosine 5'‑monophosphate‑activated protein kinase/nuclear factor‑κB pathway
   Guo‑Rong He et al, 2018, Molecular Medicine Reports CrossRef
7. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis
   Yunxia Han et al, 2021, Anti-Cancer Drugs CrossRef
8. A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma
   Xiang-Yong Hao et al, 2021, Bioscience Reports CrossRef
9. Suppression of human breast cancer cells by tectorigenin through downregulation of matrix metalloproteinases and MAPK signaling in�vitro
   Linwen Zeng et al, 2017, Molecular Medicine Reports CrossRef
10. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS
    Na Li et al, 2020, BMC Cancer CrossRef
11. HOXB9 promotes laryngeal squamous cell carcinoma progression by upregulating MMP12
    Chuanhui Sun et al, 2024, Functional & Integrative Genomics CrossRef
12. RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1
    Irina A. Elcheva et al, 2020, Leukemia CrossRef
13. Multidrug efflux transporter ABCG2: expression and regulation
    Samiksha Kukal et al, 2021, Cellular and Molecular Life Sciences CrossRef
14. Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression
    Linda S. Steelman et al, 2017, Oncotarget CrossRef
15. Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients
    Yomna M El-Meligui et al, 2022, Pharmacogenomics and Personalized Medicine CrossRef
16. Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps
    Silvia Di Giacomo et al, 2019, Archives of Toxicology CrossRef
17. Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
    Mikhail G. Dozmorov et al, 2023, Scientific Reports CrossRef
18. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo
    Rui-Ming Liu et al, 2020, Phytomedicine CrossRef
19. Context-dependent HOX transcription factor function in health and disease
    Sarah E. Bondos et al, 2020, Dancing Protein Clouds: Intrinsically Disordered Proteins in Health and Disease, Part B CrossRef
20. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
    Sunbin Ling et al, 2017, Molecular Oncology CrossRef
21. MicroRNA‐128/homeobox B8 axis regulates ovarian cancer cell progression
    Rui Li et al, 2019, Basic & Clinical Pharmacology & Toxicology CrossRef
22. Circular RNAs in drug resistant tumors
    Xin Hua et al, 2019, Biomedicine & Pharmacotherapy CrossRef
23. Identification of ubiquitination-related genes in human glioma as indicators of patient prognosis
    Lei Wang et al, 2021, PLOS ONE CrossRef
24. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
    Marius Farcas et al, 2019, Frontiers in Nutrition CrossRef
25. Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13
    Guangqi Zhou et al, 2017, Oncology Letters CrossRef
26. ATP‑binding cassette transporter A1: A promising therapy target for prostate cancer (Review)
    Ting Xiong et al, 2017, Molecular and Clinical Oncology CrossRef
27. Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells
    Hao Xu et al, 2020, Journal of Biosciences CrossRef
28. HOXB4 knockdown enhances the cytotoxic effect of paclitaxel and cisplatin by downregulating ABC transporters in ovarian cancer cells
    Ying Li et al, 2018, Gene CrossRef
29. HOXB4 inhibits the proliferation and tumorigenesis of cervical cancer cells by downregulating the activity of Wnt/β-catenin signaling pathway
    Dan Lei et al, 2021, Cell Death & Disease CrossRef
30. Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention
    Yangyang Feng et al, 2021, Frontiers in Oncology CrossRef
31. The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia
    Arne Velthaus et al, 2019, Cancers CrossRef
32. Molecular implications of HOX genes targeting multiple signaling pathways in cancer
    U Sangeetha Shenoy et al, 2022, Cell Biology and Toxicology CrossRef